Sign up to receive this weekly briefing and regular updates from Wolters Kluwer.

Briefing Archive:   August 8 | August 1 | July 25 | July 18 | July 11 | July 4 | June 27 | June 20

June 13 | June 6 | May 30 | May 23 | May 16 | May 9 | May 2 | April 25 | April 18 | April 11

August 15, 2020

FEATURED ARTICLE

Nurses’ Mental Health During the COVID-19 Outbreak

Explore the factors that might accentuate the negative consequences on nurses’ mental health status during the COVID-19 outbreak in this new article. 

"Overall, nurses who did not consider the quantity and quality of PPE  as adequate presented significantly higher levels of depression, anxiety, and stress," finds Francisco Miguel CorreiaSampaio, PhD and colleagues. 

Early Impact of COVID-19 on Solid Organ Transplantation in the United States

The regional impact of COVID-19 on solid organ transplantation in the United States has not been fully evaluated. In this paper, a retrospective analysis of month-to-month trends was performed.

READ MORE >

Electrocautery, Diathermy, and Surgical Energy Devices: Are Surgical Teams at Risk During the COVID-19 Pandemic?

This study provides a rapid synthesis of available data to identify the risk posed by utilizing surgical energy devices intraoperatively due to the generation of surgical smoke, an aerosol. 

LEARN MORE >

SARS-CoV-2 Pneumonia with Subcutaneous Emphysema, Mediastinal Emphysema, and Pneumothorax: A Case Report

Subcutaneous emphysema and pneumothorax are uncommon complications of SARS-CoV-2 pneumonia. In this paper, the authors describe a fatal case with multiple rare complications.

VIEW FULL ARTICLE >

Are Hospitals Safe? A Prospective Study on SARS-CoV-2 Prevalence and Outcome on Surgical Fracture Patients

In this original study, researchers describe clinical characteristics of fracture patients, including a closer look to hip fracture patients, and determine how epidemiological variables may have influenced on a higher vulnerability to SARS-CoV-2 infection, as the basis for the considerations needed to reintroduce elective surgery during the pandemic.

KEEP READING >

PODCAST

"COVID-19: The Impact on Plastic Surgery and the World" with Robert Pearl, MD and Rod Rohrich, MD

The PRS Global Open articles referenced in this episode are free to read. Access them today.

STAY UPDATED BETWEEN
WEEKLY BRIEFINGS

Below are our additional COVID-19 resources to keep you informed.

COVID-19 Briefing Archive

COVID-19 Resources on Ovid®

Wolters Kluwer Health Clarity Hub

COVID-19 Resources for Nurses

COVID-19 Pandemic: Understanding Patterns and Outcomes in Critically Ill Patients

As a medical community and a society, we have collectively witnessed a significant evolution of knowledge commensurate to the discovery and widespread dissemination of a new disease. This article provides insights on the following topics: Pattern with clinical presentation, COVID-19 and coagulation, Chronic co-morbidities, and more.

VIEW FULL ARTICLE >

Just-in-Time Simulation to Guide Workflow Design for COVID-19 Difficult Airway Management

As part of The Children’s Hospital of Philadelphia's COVID-19 critical care workflow design process, a number of simulation exercises were developed and conducted, increasing in complexity, progressing to intubation wearing personal protective equipment, and culminating in activation of our difficult airway team for an airway emergency.

KEEP READING >

Cardiovascular Hospitalizations, Influenza Activity, and COVID-19 Measures

During the COVID-19 pandemic there have been reports suggesting a decrease in hospitalizations for cardiovascular disease, including acute myocardial infarction and heart failure. This reduction does not only relate to temporarily postponed elective
procedures, but also acute and life-threatening conditions.

READ MORE >

Current Perspectives of Anticoagulation in Patients With COVID-19

The antiviral agent remdesivir has become a viable option and is now available in the United States for hospitalized patients through an emergency use authorization. This article describes remdesivir’s historical background, pharmacology, key trials, adverse events, and issues around accessibility.

VIEW FULL ARTICLE >